These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10431358)

  • 1. Study by means of high-performance liquid chromatography of solutes that decrease theophylline/protein binding in the serum of uremic patients.
    De Smet R; Vogeleere P; Van Kaer J; Lameire N; Vanholder R
    J Chromatogr A; 1999 Jun; 847(1-2):141-53. PubMed ID: 10431358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug protein binding in chronic renal failure: evaluation of nine drugs.
    Vanholder R; Van Landschoot N; De Smet R; Schoots A; Ringoir S
    Kidney Int; 1988 May; 33(5):996-1004. PubMed ID: 3392889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
    Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
    J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of urea and other uremic markers for quantification of dialysis efficacy.
    Vanholder RC; De Smet RV; Ringoir SM
    Clin Chem; 1992 Aug; 38(8 Pt 1):1429-36. PubMed ID: 1643710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-bound uremic retention solutes.
    Brunet P; Dou L; Cerini C; Berland Y
    Adv Ren Replace Ther; 2003 Oct; 10(4):310-20. PubMed ID: 14681860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Ionic Strength, pH and Chemical Displacers on the Percentage Protein Binding of Protein-Bound Uremic Toxins.
    Shi Y; Tian H; Wang Y; Shen Y; Zhu Q; Ding F
    Blood Purif; 2019; 47(4):351-360. PubMed ID: 30562731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.
    Mabuchi H; Nakahashi H
    Ther Drug Monit; 1988; 10(3):261-4. PubMed ID: 3140432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and quantification of a protein-bound ligand in uremic serum.
    Takeda N; Niwa T; Tatematsu A; Suzuki M
    Clin Chem; 1987 May; 33(5):682-5. PubMed ID: 3568353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of uremic serum and uremic toxins on hepatic uptake of digoxin.
    Tsujimoto M; Kinoshita Y; Hirata S; Otagiri M; Ohtani H; Sawada Y
    Ther Drug Monit; 2008 Oct; 30(5):576-82. PubMed ID: 18708994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.
    Tsutsumi Y; Deguchi T; Takano M; Takadate A; Lindup WE; Otagiri M
    J Pharmacol Exp Ther; 2002 Nov; 303(2):880-7. PubMed ID: 12388676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia.
    Takamura N; Maruyama T; Otagiri M
    Clin Chem; 1997 Dec; 43(12):2274-80. PubMed ID: 9439444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and sensitive method for simultaneous determination of eight protein-bound uremic toxins in human serum by UHPLC-MS/MS: application in assessing peritoneal dialysis.
    Wang Z; Jiang H; Chen X; Song X; Xu F; Chen F; Mao Z; Gao S; Chen W
    J Pharm Biomed Anal; 2020 Jul; 186():113312. PubMed ID: 32361090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of renal transplantation on a major endogenous ligand retained in uremic serum.
    Mabuchi H; Nakahashi H; Hamajima T; Aikawa I; Oka T
    Am J Kidney Dis; 1989 Jan; 13(1):49-54. PubMed ID: 2643310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal theophylline levels in plasma by fluorescence polarization immunoassay in patients with renal disease.
    Patel JA; Clayton LT; LeBel CP; McClatchey KD
    Ther Drug Monit; 1984; 6(4):458-60. PubMed ID: 6515707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of free and protein bound uremic toxins in human serum by LC-MS/MS: Comparison of rapid equilibrium dialysis and ultrafiltration.
    Fabresse N; Uteem I; Lamy E; Massy Z; Larabi IA; Alvarez JC
    Clin Chim Acta; 2020 Aug; 507():228-235. PubMed ID: 32371217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of UV-absorbing solutes in uremic serum by reversed phase HPLC--change of blood levels in different therapies.
    Schoots AC; Homan HR; Gladdines MM; Cramers CA; de Smet R; Ringoir SM
    Clin Chim Acta; 1985 Feb; 146(1):37-51. PubMed ID: 3987038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.